| Dr Aman A Shah, MD | |
|
100 Hillcrest Medical Blvd, Waco, TX 76712 | |
| (254) 202-2000 | |
| Not Available |
| Full Name | Dr Aman A Shah |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 100 Hillcrest Medical Blvd, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033132758 | NPI | - | NPPES |
| 178011602 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Hillcrest | Waco, TX | Hospital |
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hillcrest Physician Services | 1153304456 | 90 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Hillcrest Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649294323 PECOS PAC ID: 1153304456 Enrollment ID: O20040609000104 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Curana Health Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255640678 PECOS PAC ID: 9133304603 Enrollment ID: O20110427000111 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Lonestar Hospital Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518237429 PECOS PAC ID: 6709049703 Enrollment ID: O20120530000620 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Fort Parker Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720334964 PECOS PAC ID: 6406003011 Enrollment ID: O20120904000055 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | National Medical Professionals Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912120874 PECOS PAC ID: 3375859408 Enrollment ID: O20150903000965 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801300322 PECOS PAC ID: 7618237264 Enrollment ID: O20180131000478 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aman A Shah, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 215-9790 | Dr Aman A Shah, MD 100 Hillcrest Medical Blvd, Waco, TX 76712 Ph: (254) 202-2000 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The New York Times is reporting that Democratic congressional leaders and President Barack Obama "have reached a tentative deal on a proposed excise tax on high-cost, employer-sponsored insurance plans to be included in the final version of major health care legislation, according to officials familiar with the talks." Details of the compromise were not available.
› Verified 6 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Dr. Rita L Haws, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 Fax: 254-313-4549 |